HER2/neu, Topoisomerase 2a, Estrogen and Progesterone Receptors: Discordance between Primary Breast Cancer and Metastatic Axillary Lymph Node in Expression and Amplification Characteristics-Reference-Cited by-同舟云学术

HER2/neu, Topoisomerase 2a, Estrogen and Progesterone Receptors: Discordance between Primary Breast Cancer and Metastatic Axillary Lymph Node in Expression and Amplification Characteristics

Published:2012 Issue:6 Volume:7 Page:465-470
ISSN:1661-3805
Container-title:Breast Care
language:en
Short-container-title:Breast Care

Author:

Ataseven Beyhan,Gologan Daniela,Gunesch Angela,Kehl Victoria,Hoegel Bernhard,Beer Michaela,Eiermann Wolfgang

Publisher

S. Karger AG

Subject

Oncology,Surgery

Reference29 articles.

1. Immunohistochemical expression of hormone receptors in invasive breast carcinoma: correlation of results of H-score with pathological parameters

2. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

3. HER2and Responsiveness of Breast Cancer to Adjuvant Chemotherapy

4. c-erbB2 expression predicts tamoxifen efficacy in breast cancer patients

5. HER2 Status and Efficacy of Adjuvant Anthracyclines in Early Breast Cancer: A Pooled Analysis of Randomized Trials

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HER2-low metastases of HER2-negative primary tumors: a single institution analysis of intertumoral and internodal heterogeneity in node-positive breast cancer;Frontiers in Oncology;2023-07-07

2. Clinical relevance of biomarker discordance between primary breast cancers and synchronous axillary lymph node metastases;Clinical & Experimental Metastasis;2023-07-01

3. Biomarker heterogeneity between primary breast cancer and synchronous axillary lymph node metastases;Oncology Letters;2020-09-21

The Prognostic Impact of Hormonal Receptor and HER-2 Expression Discordance in Metastatic Breast Cancer Patients

;OncoTargets and Therapy;2020-01

5. Study of ER, PR, HER2/neu, p53, and Ki67 expression in primary breast carcinomas and synchronous metastatic axillary lymph nodes;Indian Journal of Cancer;2020